Through human triple-negative breast cancer dataset analysis, GAD1 expression is stage-dependent, with an initial increase and then decrease in stage IV, comparing metastatic versus non-metastatic cases (Figure S4). The gene discussed is GAD1; the disease is triple-negative breast carcinoma.